Need to file an Actos lawsuit? Contact Williams Kherkher today at 800-641-9810.

Takeda Pharmaceutical prepares for Actos patent to expire

Posted on May 16th, 2012 No Comments

As Takeda Pharmaceutical’s patent on Actos gets closer to its August expiration, the company is making efforts to offset the decreased profits it will lose to generic versions of the drug.

The company expects to miss out on over $2 billion in revenue to generic versions of its flagship drug.

Takeda has been preparing for this potential shift for a good length of time. The Japanese pharmaceutical giant has spent nearly $15 billion on overseas acquisitions over the past two years. The company’s acquisition of URL Pharma will allow access to profits made by the drug Colcrys, which is used to treat and prevent gout.

Actos has been strongly linked to bladder cancer. Many people who have been diagnosed with bladder cancer after taking Actos have joined mass tort lawsuits against Takeda. If you have suffered from the deadly adverse side effects of Actos, contact the Actos lawsuit counsel of Williams Kherkher at 800-641-9810.

Tagged , , | Leave a comment

Contact Williams Kherkher

By submitting this form, you certify that you agree to our terms and conditions and wish to be contacted regarding your inquiry.

home  |  about us  |  attorneys  |  actos  |  bladder cancer  |  faqs  |  articles  |  law resources  |  press release  |  contact us  |  blog  |  Log in
Copyright ©2007-2010 Williams Kherkher. Attorneys are licensed only in the state of Texas unless otherwise indicated in the biographical section. Past performance is no guarantee of future results. Williams Kherkher's primary office is located in Texas. Terms of Use. Disclaimer. Sitemap.
8441 Gulf Freeway, Suite 600, Houston, TX 77017-5051 -- 800-641-9810 | John Eddie Williams +